The day's most important news and information. A Fourth Estate® Service

Thursday, May 13, 2021
Brazil health regulator Anvisa announced on Thursday morning it has officially allowed the resumption of late-stage Brazilian clinical trials for China’s Sinovac COVID-19 vaccine, which had been suspended after a study subject’s death.
This article has been archived. Log in or Subscribe to access archived content.